Correlation Between Tempest Therapeutics and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Monte Rosa.
Diversification Opportunities for Tempest Therapeutics and Monte Rosa
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tempest and Monte is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Monte Rosa go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Monte Rosa
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, Tempest Therapeutics is 4.32 times less risky than Monte Rosa. The stock trades about -0.12 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 487.00 in Monte Rosa Therapeutics on August 25, 2024 and sell it today you would earn a total of 362.00 from holding Monte Rosa Therapeutics or generate 74.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Tempest Therapeutics |
| Monte Rosa Therapeutics |
Tempest Therapeutics and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Monte Rosa
The main advantage of trading using opposite Tempest Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. RenovoRx | Tempest Therapeutics vs. Scpharmaceuticals |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. HCW Biologics | Monte Rosa vs. RenovoRx | Monte Rosa vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |